NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

Download a CSV of all Patent records.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset Search to show all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NHLBI E-273-2015-0-US-01 Endo-cameral Closure Device US 62/236,734 Abandoned
NHLBI E-165-2015-0-US-01 LENTIVIRAL PROTEIN DELIVERY SYSTEM FOR RNA-GUIDED GENOME EDITING US 62/236,223 Abandoned
NICHD E-057-2008-0-US-53 METHOD FOR TREATING UTERINE FIBROIDS US CON 14/872,320 9682088 Abandoned PDF
NCATS E-018-2015-0-PCT-02 COMPOSITIONS AND METHODS FOR INHIBITING BMP PCT PCT PCT/US2015/053545 Expired
NCATS E-018-2015-0-EP-04 COMPOSITIONS AND METHODS FOR INHIBITING BMP EP National Stage 15846595.5 Abandoned
NIAID E-043-2011-0-US-10 Adenovirus Serotype 26 and Serotype 35 Filovirus Vaccines US National Stage 13/994,532 9701718 Issued PDF
NCI E-208-2015-0-US-01 THALIDOMIDE ANALOGS AND METHODS OF USE US 62/235,105 Abandoned
NIDCR E-018-2003-0-US-12 Postnatal Stem Cells and Uses Thereof US CON 14/869,565 9682107 Expired PDF
NIDDK E-284-2008-0-US-16 Low Molecular Weight Thyroid Stimulating Hormone Receptor (TSHR) Agonists US CON 14/869,318 9458141 Issued PDF
NHGRI E-081-2014-0-PCT-02 Methods Of Treating PXE With TNAP Inhibitors PCT PCT PCT/US2015/052967 Expired
NCATS E-060-2017-0-US-01 Compositions and Methods for Identifying and Treating Dystonia Disorders US 62/234,127 Abandoned
NINDS E-024-2016-0-US-01 Methods of Treating and Preventing Amyotrophic Lateral Sclerosis (ALS) US 62/234,419 Abandoned
NCI E-106-2014-0-NZ-13 YEAST-BASED IMMUNOTHERAPY FOR CHORDOMA NZ National Stage 712817 Abandoned
NCI E-205-2010-2-US-09 Photosensitizing Antibody-Fluorophore Conjugates US DIV 14/868,040 10537641 Issued PDF
NCI E-043-2008-0-US-05 ANTI-HIV DOMAIN ANTIBODIES AND METHOD OF MAKING AND USING SAME US CON 14/867,793 10287340 Issued PDF
NCI E-217-2010-2-US-03 A Method For The Treatment Of Obesity US CON 14/868,038 Abandoned
NIAID E-181-2014-0-EP-05 Virus-Based Expression Vectors and Uses Thereof EP National Stage 15775581.0 Issued
NIAID E-181-2014-0-GB-10 Virus-Based Expression Vectors and Uses Thereof GB EP 15775581.0 Issued
NIAID E-181-2014-0-NL-11 Virus-Based Expression Vectors and Uses Thereof NL EP 15775581.0 Issued
NIAID E-181-2014-0-DK-08 Virus-Based Expression Vectors and Uses Thereof DK EP 15775581.0 Issued
NIAID E-181-2014-0-FR-09 Virus-Based Expression Vectors and Uses Thereof FR EP 15775581.0 Issued
NIAID E-181-2014-0-DE-07 Virus-Based Expression Vectors and Uses Thereof DE EP 15775581.0 Issued
NIAID E-181-2014-0-CA-04 Virus-Based Expression Vectors and Uses Thereof CA National Stage 2962100 Issued
NIAID E-181-2014-0-AU-03 Virus-Based Expression Vectors and Uses Thereof AU National Stage 2015320409 Issued
NIAID E-181-2014-0-PCT-02 Virus-Based Expression Vectors and Uses Thereof PCT PCT PCT/US2015/052295 Expired
NCI E-171-2018-1-US-01 NON-VIRAL MODIFIED CELLS AND METHODS OF THERAPY US 62/232,983 Abandoned
NIDDK E-213-2015-0-US-01 Triazole Derivatives As P2Y14 Receptor Antagonists US 62/233,162 Abandoned
NCI E-104-2013-0-US-03 Anti-CD276 Polypeptides, Proteins, and Chimeric Antigen Receptors US National Stage 14/779,586 9790282 Issued PDF
NIAID E-300-2009-5-US-10 Neutralizing Antibodies to HIV-1 and Their Use US DIV 14/864,705 9738703 Issued PDF
NIBIB E-232-2014-0-PCT-02 Resolution Enhancement for Light Sheet Microscopy Systems and Methods PCT PCT PCT/US2015/052047 Expired
NIBIB E-232-2014-0-EP-03 Resolution Enhancement for Light Sheet Microscopy Systems and Methods EP National Stage 15843742.6 Abandoned
NCI E-278-2015-1-US-01 Human RPN2 Derived Peptides Useful For Treating Cancer US 62/232,144 Abandoned
NCI E-278-2015-0-US-01 Human RPN2 Derived Peptides Useful For Treating Cancer US 62/222,530 Abandoned
NIBIB E-225-2014-0-EP-03 Resolution Enhancement For Line Scanning Excitation Microscopy Systems And Methods EP National Stage 15775866.5 Abandoned
NIBIB E-225-2014-0-GB-09 Resolution Enhancement For Line Scanning Excitation Microscopy Systems And Methods GB EP 15775866.5 Abandoned
NIBIB E-225-2014-0-FR-08 Resolution Enhancement For Line Scanning Excitation Microscopy Systems And Methods FR EP 15775866.5 Abandoned
NIBIB E-225-2014-0-IE-10 Resolution Enhancement For Line Scanning Excitation Microscopy Systems And Methods IE EP 15775866.5 Abandoned
NIBIB E-225-2014-0-DE-07 Resolution Enhancement For Line Scanning Excitation Microscopy Systems And Methods DE EP 15775866.5 Abandoned
NIBIB E-225-2014-0-CH-06 Resolution Enhancement For Line Scanning Excitation Microscopy Systems And Methods CH EP 15775866.5 Abandoned
NIBIB E-225-2014-0-PCT-02 Resolution Enhancement For Line Scanning Excitation Microscopy Systems And Methods PCT PCT PCT/US2015/051422 Expired
NIAID E-055-2007-3-US-04 Use of Antagonists Of The Interaction Between HIV Gp120 And A4B7 Intregrin US DIV 14/859,675 9441041 Abandoned PDF
NCI E-264-2015-0-US-01 Monoclonal Antibodies Specific for Fibroblast Growth Factor Receptor 4 (FGFR4) and Methods of Their Use US 62/221,045 Abandoned
NIAID E-145-2015-3-PCT-01 Substituted Phenylpyrrolecarboxamides With Therapeutic Activity In HIV PCT PCT COMB PCT/US2015/051086 Expired
NIDCR E-232-2011-1-US-04 METHODS FOR THE DIAGNOSIS AND TREATMENT OF SJOGRENS SYNDROME US CON 14/858,929 Abandoned
NCI E-106-2014-0-JP-10 YEAST-BASED IMMUNOTHERAPY FOR CHORDOMA JP National Stage 2016-504343 Issued
NHGRI E-177-2015-0-US-01 New Pan-Cancer Detection Methods US 62/220,041 Abandoned
NIAID E-064-2015-1-US-01 Myelin Oligodendrocyte Glycoprotein, Myelin Basic Protein, and Proteolipid Protein Compositions and Methods of Use US 62/219,851 Abandoned
NIAID E-065-2018-0-US-01 COMPOSITIONS COMPRISING PREGNANCY SPECIFIC GLYCOPROTEINS AND METHODS OF USE THEREOF US 62/219,900 Abandoned
NCI E-250-2014-0-CA-03 Anti-CD276 Antibodies (B7H3) CA National Stage 2961609 Issued
NCI E-250-2014-0-ES-01 Anti-CD276 Antibodies (B7H3) ES EP 15772128.3 Issued